@article{7c4621087a2b4d2998c158f7595c9c9d,
title = "2018 Korean clinical imaging guideline for hemoptysis",
abstract = "In 2014, the American College of Radiology (ACR) announced the guideline for the appropriate diagnostic approach and treatment of patients according to the severity of hemoptysis and risk for lung cancer. However, the application of the ACR guideline in Korea may not be appropriate, because many patients in Korea have active tuberculosis or pulmonary fibrosis due to previous tuberculosis. The Korean Society of Radiology and Korean Society of Thoracic Radiology have proposed a new guideline suitable for Korean practice. This new guideline was prepared through the consensus of a development committee, working party, and an advisory committee. The guideline proposal process was based on an evidence-based clinical imaging guideline proposed by the development committee. Clinical imaging guideline for adult patients with hemoptysis is as follows: Chest radiography is an initial imaging modality to evaluate hemoptysis. Contrast-enhanced chest CT is recommended in patients with two risk factors for lung cancer (> 40 years old and > 30 pack-year smoking history), moderate hemoptysis (> 30 mL/24 hours) or recurrent hemoptysis. Contrast-enhanced chest CT is also recommended in patients with massive hemoptysis (> 400 mL/24 hours) without cardiopulmonary compromise.",
keywords = "Computed tomography, Evidence, Guideline, Hemoptysis, Lung, Radiography, Republic of korea, Thorax, X-ray",
author = "Kang, {Mi Jin} and Kim, {Jin Hwan} and Kim, {Yoon Kyung} and Lee, {Hyun Joo} and Shin, {Kyung Min} and Kim, {Jung Im} and Lee, {Hyun Ju} and Do, {Kyung Hyun} and Yong, {Hwan Seok} and Choi, {Sol Ji} and Miyoung Choi and Jung, {Jung Im}",
note = "Funding Information: This study was supported by the National Evidence-based Collaborating Agency (NECA-C-15-003) and the Korean Society of Radiology (NECA-S-15-002). Funding Information: Received February 22, 2018; accepted after revision April 3, 2018. This study was supported by the National Evidence-based Collaborating Agency (NECA-C-15-003) and the Korean Society of Radiology (NECA-S-15-002). This Guideline has been published jointly by invitation and consent in both the Journal of the Korean Society of Radiology (in Korean) and the Korean Journal of Radiology (in English). Corresponding author: Jung Im Jung, MD, PhD, Department of Radiology, Seoul St. Mary{\textquoteright}s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea. • Tel: (822) 2258-1435 • Fax: (822) 599-6771 • E-mail: jijung@catholic.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Publisher Copyright: {\textcopyright} 2018 The Korean Society of Radiology.",
year = "2018",
month = sep,
day = "1",
doi = "10.3348/kjr.2018.19.5.866",
language = "English",
volume = "19",
pages = "866--871",
journal = "Korean Journal of Radiology",
issn = "1229-6929",
publisher = "Korean Radiological Society",
number = "5",
}